• Contemporary ClinicContemporary Clinic
  • OTC GuideOTC Guide
  • Pharmacy Times
  • PTCEPTCE
  • Pharmacist Moms GroupPharmacist Moms Group
News
All News
FDA Updates
Press Releases
Media
All Videos
Digital Detail
Independent Corner
Insights
Interviews
MEDcast
Medical World News
Microsites
Peer Exchange
Perfect Consult
Podcasts
Practice Pearls
Sponsored Webcast
Student Voices
Webinars/Webcasts
Conferences
Conference Coverage
Conference Listing
Publications
Pharmacy Times
Pharmacy Practice in Focus: Oncology
Pharmacy Practice in Focus: Health Systems
Pharmacy Careers
All Publications
About the Publications
Author Submission
Submit to Pharmacy Practice in Focus: Oncology
Submit to Pharmacy Practice in Focus: Health Systems
Become a Peer Reviewer
Supplements & Featured Publications
Clinical
503B Compounding Pharmacy
ADHD
Allergy
Alzheimer Disease
Anxiety
Asthma
Atopic Dermatitis
Biosimilars
Bipolar Disorder
Brain Health
Breast Cancer
C. Difficile
COPD
COVID-19
Cardiovascular Health
Cervical Cancer
Cholangiocarcinoma
Cholesterol
Chronic Kidney Disease
Chronic Lymphocytic Leukemia
Classical Hematology
Colorectal Cancer
Continuous Glucose Monitoring
Cough and Cold
Depression
Dermatology
Diabetes
Digestive Health
Dry Eye Disease
Epilepsy
Eye Care
Flu
Future of Pharmacy
Gastrointestinal Cancer
Gastrointestinal Health
Gout
HER2 Breast Cancer
HIV
Heart Failure
Hematology
Hepatitis/MASH
Immunization
Immuno-oncology
Immunoglobulins
Infectious Disease
Lung Cancer
Lymphoma
Macular Degeneration
Mental Health
Migraine
Movement Disorders
Multiple Myeloma
Multiple Sclerosis
Myelofibrosis
Neurology
Neutropenia
Osteoporosis
Ovarian Cancer
Pain Management
Parkinson Disease
Pediatrics
Pharmacy Heroes
Pharmacy Management
Pneumococcal
PrEP
Prostate Cancer
Psoriasis
Psoriatic Arthritis
Psychedelics
Reimbursement
Reproductive Health
Respiratory Syncytial Virus
Rheumatoid Arthritis
Schizophrenia
Shingles
Skin Cancer
Sleep
Travel Vaccines
Veterinary Pharmacy
Vitamins and Supplements
Weight Management
Women's Health
Events
Upcoming Events
Upcoming Webinars
CE
Resources
Clinical Forum
Cou-Co
Educated Patient
Information for the Pharmacist
Interactive Tools
Partners
Sponsored
Whiteboards
Subscribe
logo
Spotlight
Community/RetailHospitalOncologyPharmacy TechnicianStudent
Clinical Role
Community/RetailHospitalOncologyPharmacy TechnicianSpecialty PharmacyStudent
Clinical
CoronavirusBrain HealthCardiovascular HealthDermatologyDiabetesFluHeart FailureHepatitis/MASHImmunizationMigrainePneumococcalVitamins and Supplements
Supplement Spotlight
October 2023 Pharmacy Technician Edition
All News
FDA Updates
Press Releases
All Videos
Digital Detail
Independent Corner
Insights
Interviews
MEDcast
Medical World News
Microsites
Peer Exchange
Perfect Consult
Podcasts
Practice Pearls
Sponsored Webcast
Student Voices
Webinars/Webcasts
Conference Coverage
Conference Listing
Pharmacy Times
Pharmacy Practice in Focus: Oncology
Pharmacy Practice in Focus: Health Systems
Pharmacy Careers
All Publications
About the Publications
Author Submission
Submit to Pharmacy Practice in Focus: Oncology
Submit to Pharmacy Practice in Focus: Health Systems
Become a Peer Reviewer
Supplements & Featured Publications
503B Compounding Pharmacy
ADHD
Allergy
Alzheimer Disease
Anxiety
Asthma
Atopic Dermatitis
Biosimilars
Bipolar Disorder
Brain Health
Breast Cancer
C. Difficile
COPD
COVID-19
Cardiovascular Health
Cervical Cancer
Cholangiocarcinoma
Cholesterol
Chronic Kidney Disease
Chronic Lymphocytic Leukemia
Classical Hematology
Colorectal Cancer
Continuous Glucose Monitoring
Cough and Cold
Depression
Dermatology
Diabetes
Digestive Health
Dry Eye Disease
Epilepsy
Eye Care
Flu
Future of Pharmacy
Gastrointestinal Cancer
Gastrointestinal Health
Gout
HER2 Breast Cancer
HIV
Heart Failure
Hematology
Hepatitis/MASH
Immunization
Immuno-oncology
Immunoglobulins
Infectious Disease
Lung Cancer
Lymphoma
Macular Degeneration
Mental Health
Migraine
Movement Disorders
Multiple Myeloma
Multiple Sclerosis
Myelofibrosis
Neurology
Neutropenia
Osteoporosis
Ovarian Cancer
Pain Management
Parkinson Disease
Pediatrics
Pharmacy Heroes
Pharmacy Management
Pneumococcal
PrEP
Prostate Cancer
Psoriasis
Psoriatic Arthritis
Psychedelics
Reimbursement
Reproductive Health
Respiratory Syncytial Virus
Rheumatoid Arthritis
Schizophrenia
Shingles
Skin Cancer
Sleep
Travel Vaccines
Veterinary Pharmacy
Vitamins and Supplements
Weight Management
Women's Health
Upcoming Events
Upcoming Webinars
CE
Clinical Forum
Cou-Co
Educated Patient
Information for the Pharmacist
Interactive Tools
Partners
Sponsored
Whiteboards
Subscribe
Advertisement

CLINICAL ROLE -

Community/Retail
| Hospital
| Oncology
| Pharmacy Technician
| Student

News

Article

September 5, 2023

Study Finds Inadequate Emotional Support, Lower Health-Related Quality of Life, Increased Odds of Depression in Adults With Gastrointestinal Cancers

Author(s):

Gillian McGovern, Associate Editor

Additional research is needed to further evaluate whether adequate emotional support is linked to improvements in health-related quality of life in adults diagnosed with other cancer.

Compared to those without cancer, older adults with cancer are more likely to experience depression, anxiety, and poor quality of life, according to study authors at the University of Alabama at Birmingham who recently published their research in Cancer Medicine. An important component of health-related quality of life (HRQoL) is social support, particularly emotional support (ES), which is defined as the perception that an individual has in an intrapersonal relationship in which they can effectively share their emotions and be understood.

Two women holding each others' hands

Image credit: Dragana Gordic | stock.adobe.com

This cross-sectional study examined older adults with gastrointestinal (GI) malignancies and ES and its associations with HRQoL, mental health, and survival. Investigators measured ES using an adaptation of the Medical Outcomes Study (dichotomized adequate ES versus inadequate ES). Outcomes included physical and mental HRQoL, anxiety, depression, and survival. Multivariable linear regression evaluated the link between ES and HRQoL scores, and multivariable logistic regression evaluated the association of ES with anxiety and depression. If necessary, adjustments were made for age at geriatric assessments (GA), race, sex, and cancer stage and type.

The study authors examined 795 adults aged 60 years or older who were newly diagnosed with GI cancer and undergoing geriatric assessment at their first clinic visit. The most common malignancies in the study were colorectal (37.9%, n = 274) and pancreatic cancer (30.8%, n = 223), with 72.1% (n = 564) diagnosed as stage III or IV disease. Further, most participants were married (61.9%) and retired (61.2%). Patients were selected from the Cancer & Aging Resilience Evaluation (CARE) registry, which is an ongoing prospective study of older adults with cancer that combines self-reported GA (also called CARE tool) and follow-up outcomes.

Results indicated that in older adults with GI cancers, inadequate ES was associated with lower physical and mental HRQoL and increased odds of depression. Patients with inadequate ES were more likely to be non-White, disabled, or not married (eg, single, divorced, or widowed). However, inadequate ES was not found to be linked with worse overall survival.

Approximately 77.6% of patients had adequate ES, and more than 80% had noted they had each type of emotional support “most” or “all of the time”. Those with inadequate ES were more likely to be Black (31.5% versus 20.8%, p = 0.005) or another race (3.4% vs. 1.9% p = 0.005), and less likely to be White (65.2% vs. 77.3%, p = 0.005). Patients with inadequate ES were more likely to have a disability (24.1% vs. 10.4%, p < 0.001) and less likely to be retired (56.0% vs. 62.6%, p < 0.001), employed part-time (3.0% vs. 3.5%, p < 0.001) or employed full time (8.4% vs. 13.1%, p < 0.001). Further, more patients with insufficient ES were less likely to be married (32.7% vs. 70.1%, p < 0.001), and more likely to be widowed, divorced, or separated (54.2% vs. 24.8%, p < 0.001) or single (13.1% vs. 5.2%, p < 0.001). Additionally, those with insufficient ES were shown to have higher odds of depression (aOR: 2.22, CI: 1.34–3.69).

The median follow-up time during the study period was 14 months (IQR: 8 to 31 months) and 36.7% (n = 292) of participants died during the study period; 24.3% of participants who died were deceased within 1 year of diagnosis, and 32.6% were deceased within 2 years of diagnosis. However, there were no differences between those with adequate ES and those without adequate ES in the proportion of deaths during the study period (36.6% vs. 37.1%, p = 0.913) within 1 year of diagnosis (24.3% vs. 24.2%, p = 0.966) and within 2 years of diagnosis (32.4% vs. 33.2%, p = 0.126). Further, there was no significant variance in survival probability between patients who had adequate ES versus those without (1-year survival: p = 0.940; 2-year survival: p = 0.544; overall survival: p = 0.506).

The authors noted that study limitations included the inability to generalize results (the study was conducted in one medical center), HRQoL and ES were measured at one point in time which can affect the established connection, and the data was self-reported by patients which could introduce information bias or misinformation. Similarly, the measures of anxiety and depression were solely patient reported which may not correlate with clinical diagnoses made by health care professionals. Further, >80% of patients had reported adequate ES in each survey question; therefore, the frequency of inadequate ES was rather low. Unlike previous research, the current study did not measure differences between received and perceived ES.

Reference

Clausing, D, Fowler, ME, Harmon, C, et al. Association of emotional support with quality of life, mental health, and survival in older adults with gastrointestinal malignancies–Results from the CARE registry. Cancer Med. 2023; 00: 1-10. doi:10.1002/cam4.6477

Newsletter

Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.

Subscribe Now!
Related Videos
Tired scared retiree man holding chest with anginal symptoms, pallor and diaphoresis at home. Suffering male with cardiac origin pain, prexcordial pressure, arrhythmia risk, urgent medical attention - Image credit: DimaBerlin | stock.adobe.com
Image credit: Sebastian Kaulitzki | stock.adobe.com
Magnified bone marrow biopsy showing plasma cells with irregular nuclei and multiple myeloma tumor cells infiltrating normal hematopoietic tissue.
Related Content
Advertisement
3d illustration of Abstract medical background with Diseased liver - Image credit: Rasi | stock.adobe.com
June 17th 2025

Study: Prevalence and Clinical Implications of MASLD in Type 2 Diabetes

Kennedy Ferruggia, Assistant Editor
Concierge Pharmacy's Role in Cardio-Kidney-Metabolic Health Care
June 17th 2025

Concierge Pharmacy's Role in Cardio-Kidney-Metabolic Health Care

Craig Beavers, PharmD, FACC, FAHA, FCCP, BCCP, BCPSAQ Cardiology, CACP Aislinn Antrim, Managing Editor
fda on paper texture - Image credit: Araki Illustrations | stock.adobe.com
June 17th 2025

Garadacimab-gxii Receives FDA Approval for Hereditary Angioedema Treatment

Kennedy Ferruggia, Assistant Editor
S2. Ep 56: Insights From a Pharmacy Times Peer Exchange: How to Talk the Talk
June 3rd 2025

S2. Ep 56: Insights From a Pharmacy Times Peer Exchange: How to Talk the Talk

Alexandra Gerlach, Associate Editor
Kidneys affected by chronic kidney disease (CKD) -- Image credit: Crystal light | stock.adobe.com
June 17th 2025

Multi-Phenotype Approach Highlights Increased Power of cPCA When Identifying CKD-Related Loci

Gillian McGovern, Associate Editor
Clostridium difficile Bacteria 3D Medical Illustration.Close-up of Clostridium difficile bacteria
June 17th 2025

Heightened Awareness, Effective Treatment Options Critical to C. difficile Management

Luke Halpern, Assistant Editor
Related Content
Advertisement
3d illustration of Abstract medical background with Diseased liver - Image credit: Rasi | stock.adobe.com
June 17th 2025

Study: Prevalence and Clinical Implications of MASLD in Type 2 Diabetes

Kennedy Ferruggia, Assistant Editor
Concierge Pharmacy's Role in Cardio-Kidney-Metabolic Health Care
June 17th 2025

Concierge Pharmacy's Role in Cardio-Kidney-Metabolic Health Care

Craig Beavers, PharmD, FACC, FAHA, FCCP, BCCP, BCPSAQ Cardiology, CACP Aislinn Antrim, Managing Editor
fda on paper texture - Image credit: Araki Illustrations | stock.adobe.com
June 17th 2025

Garadacimab-gxii Receives FDA Approval for Hereditary Angioedema Treatment

Kennedy Ferruggia, Assistant Editor
S2. Ep 56: Insights From a Pharmacy Times Peer Exchange: How to Talk the Talk
June 3rd 2025

S2. Ep 56: Insights From a Pharmacy Times Peer Exchange: How to Talk the Talk

Alexandra Gerlach, Associate Editor
Kidneys affected by chronic kidney disease (CKD) -- Image credit: Crystal light | stock.adobe.com
June 17th 2025

Multi-Phenotype Approach Highlights Increased Power of cPCA When Identifying CKD-Related Loci

Gillian McGovern, Associate Editor
Clostridium difficile Bacteria 3D Medical Illustration.Close-up of Clostridium difficile bacteria
June 17th 2025

Heightened Awareness, Effective Treatment Options Critical to C. difficile Management

Luke Halpern, Assistant Editor
Consent Preferences
About Us
Clinical Forums
Advertise
Contact Us
Editorial Staff
Privacy Policy
Terms & Conditions
Do Not Sell My Information
Contact Info

2 Commerce Drive
Cranbury, NJ 08512

609-716-7777

© 2025 MJH Life Sciences

All rights reserved.